Spinal cord

The most recent articles from: Spinal Cord September 2021

Spinal cord · Sep 2021

Safety and feasibility of autologous olfactory ensheathing cell and bone marrow mesenchymal stem cell co-transplantation in chronic human spinal cord injury: a clinical trial.

This is a phase I clinical trial. ⋯ Overall, this 2-year trial was not associated with any adverse findings, which may suggest the safety of autologous OEC and bone marrow MSC combination for the treatment of human SCI.

read more… mark as read…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.